leisure time -WSS

leisure time

author：comprehensive 2025-10-02 10:48:33 - browse：83965

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Change Healthcare cyberattack prompts Medicare loan program

WSS

First medicine developed to treat MASH expected to be approved soon

First medicine developed to treat MASH expected to be approved soon

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Former medical device CEO who sold dummy, plastic parts convicted of fraud

RSV shot was 90% effective at preventing hospitalizations in kids

Beware the threat of staffing cuts at the CDC

hotspot

leisure time

entertainment

Activists slam private health insurers over coverage restrictions

Trump cancels press conference intended to dispute Georgia election interference charges

At least 13 dead in Texas as scorching temps continue

Hilary expected to bring catastrophic, life

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Continuity nursing helped my family in our darkest PICU moments

How to bring more disabled researchers into academia

Affirmative action in medical school literally saved lives

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

Baltimore teen accused of firing into crowd during block party mass shooting

Amylyx ALS drug failure raises questions and concerns

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Change Healthcare payments predicted restored March 15

ProMED sees offers of support, but its future remains unclear

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

leisure time

hotspot

entertainment

focus